谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

The Efficiency and Toxicity of Anlotinib in Combination with Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen As Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study

Xi Chen,Xinyu Wei,Peizhuo Yao,Yanbin Liu,Haitao Guan,Huafeng Kang,Di Liu,Yan Diao,Xiaobin Ma,Weili Min,Changyou Shan,Yang Zhao, Fang Zhao, Yuanyuan Chen, Dong Xiao,Qing She, Youhuai Liu,Yinbin Zhang,Shuqun Zhang

Clinical breast cancer（2024）

引用 1|浏览38
关键词
Triple Negative Breast Cancer,Neoadjuvant Therapy,Anti-angiogenesis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要